YBX1 orchestrates LDHA-mediated metabolic reprogramming and NF-κB activation to drive clear cell renal cell carcinoma progression
Abstract Renal cell carcinoma (RCC) is sometimes referred to as a “metabolic disease”, as nearly all types of RCC are associated with the reprogramming of glucose and lipid metabolism. Y-box binding protein 1 (YBX1) plays a crucial regulatory role in the development and progression of various cancer...
Zapisane w:
| Główni autorzy: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Nature Publishing Group
2026-01-01
|
| Seria: | Cell Death and Disease |
| Dostęp online: | https://doi.org/10.1038/s41419-025-08261-0 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|